IndraLab

Statements

P5091 inhibits NEK2. 1 / 1

| 1

reach

"It has recently been revealed that P5091, a nonreversible USP7 inhibitor, can deplete NEK2 protein in vitro and in vivo, resulting in suppression of NEK2 downstream target, thus overcoming bortezomib resistance."

33520703

INDRA sources:

Colored badges next to statement headings correspond to evidence counts from knowledge sources, as shown below. Badges to the left of the | separator correspond to curated knowledge base sources, and badges to the right of it correspond to machine reading systems.

IndraLab

Statements

P5091 inhibits NEK2. 1 / 1

INDRA sources:

Databases

Reading